Abstract
Background
Flow diverter stent (FDS) treatment is an effective option for wide-necked intracranial aneurysms, but adequate neointimal formation and stent apposition are critical to prevent thromboembolic complications. Non-invasive, reliable imaging techniques for assessing neointimal formation remain limited. This study aimed to evaluate the utility of Dyna-3D imaging in assessing neointimal formation after FDS treatment and to compare its performance with conventional 2D-DSA.
Methods
This retrospective study included 61 patients with unruptured intracranial aneurysms treated with FDS between August 2019 and October 2024. Radiological follow-up was performed 3–6 months post-procedure using both 2D-DSA and Dyna-3D imaging. Neointimal coverage was classified into Groups A–C based on the positional relationship between the stent wires and the vessel wall (Group A = wire outside; Group B = partial overlap; Group C = the vessel wall outside). Interobserver agreement, imaging accuracy, and associated clinical factors were analyzed.
Results
Complete neointimal formation (Group A) was identified in 51 cases (83.6%; 95% CI 72.4–90.8) using Dyna-3D and 21 cases (34.4%; 95% CI 23.7–47.0) using 2D-DSA (P < .0001). Dyna-3D demonstrated superior interobserver agreement (Cohen's κ=0.893; 95% CI 0.75–1.00) compared to 2D-DSA (κ=0.459; 95% CI 0.28–0.64) in the evaluation of neointimal formation. Multivariate analysis identified younger age as a significant factor associated with Group A classification across both modalities (2D-DSA: OR 0.93, 95% CI 0.88–0.98, P = .008; Dyna-3D: OR 0.90, 95% CI 0.8–0.97, P = .018). No thromboembolic or hemorrhagic complications were identified during follow-up.
Conclusion
Dyna-3D imaging provides superior visualization of neointimal formation compared to conventional 2D-DSA and enables comprehensive circumferential assessment of stent apposition. These findings suggest that Dyna-3D may offer a useful tool for guiding post-FDS treatment management, including the potential for age-adjusted optimization of antiplatelet therapy duration.
Keywords
Get full access to this article
View all access options for this article.
References
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
